Trial Profile
A pilot study to evaluate efficacy and safety of lenalidomide and dexamethasone in patients with POEMS Syndrome pre treated or ineligible for high dose therapy.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Jul 2015
Price :
$35
*
At a glance
- Drugs Lenalidomide (Primary) ; Dexamethasone
- Indications POEMS syndrome
- Focus Therapeutic Use
- 14 Jul 2015 New trial record
- 14 Jun 2015 Primary end point met according to the abstract presented in 20th Congress of the European Haematology Association.
- 14 Jun 2015 Results presented at the 20th Congress of the European Haematology Association.